TRIA is First Entry to Home-Based Device Market Featuring Diode Laser
Technology for Hair Removal
PLEASANTON, Calif., Feb. 7 /PRNewswire/ -- SpectraGenics, a leader in light-based therapeutic beauty devices, today announced over-the-counter (OTC) clearance from the United States Food and Drug Administration (FDA) for their patented hand-held laser hair removal device designed for at-home use. The TRIA is the first hair removal laser to enter the U.S. home-based device market, an industry projected to grow exponentially over the next three years.
"The FDA clearance is the culmination of many years of research, clinical testing and innovative product design efforts," said Robert Grove, PhD, CEO, SpectraGenics. "Our engineers are the same scientists who developed the first and gold-standard professional diode laser hair removal system over 10 years ago which is still used by physicians nationwide. We've invested significant resources to harness that same light-based technology to deliver a safe, effective way for consumers to treat unwanted hair in the privacy of their homes."
The TRIA device is the first at-home device to feature a diode laser specially designed to be safe and effective for at-home use. SpectraGenics has been selling a version of the TRIA, called i-Epi, in Japan since 2005. The TRIA is the first in a series of at-home science-based beauty devices to be pioneered by SpectraGenics.
"I have been performing laser hair removal in my office for 12 years
and welcome the arrival of TRIA as an adjunct to professional laser hair
removal," said Eric F. Bernstein, MD, Clinical Associate Professor at the
University of Pennsylvania. "TRIA is simple, safe and very effective. Many
of my patients will be able to use TRIA for touch-ups in between visits as
well as on other areas not treated in-office to achieve and maintain
beautiful results, and I expect it to increase the number of patients I see
for laser h
|SOURCE SpectraGenics, Inc.|
Copyright©2008 PR Newswire.
All rights reserved